Purchase Order 75N91020P00029
- Not listed
- This federal contract award is for a maintenance agreement on various laboratory equipment, valued at $30,087.45, awarded by the National Cancer Institute (NCI) to Bio-Rad Laboratories, Inc. Life Science Group Division. The contract has an ultimate completion date of March 31, 2025. Bio-Rad Laboratories, Inc. is the parent company of the prime contractor and has established significant Indefinite Delivery Vehicles (IDVs) and Blanket Purchase Agreements (BPAs) with various federal agencies,...
- This is a firm fixed-price purchase order awarded by the Department of Health and Human Services National Institutes of Health National Cancer Institute to Bio-Rad Laboratories, Inc. Life Science Group Division, a subsidiary of Bio-Rad Laboratories, Inc. The $10,188.00 contract is for a service agreement with a completion date of May 13, 2025. The contract does not have a set-aside designation. Bio-Rad Laboratories, Inc. is an experienced federal contractor that provides a variety of...
- This federal contract award is for a MAINTENANCE AGREEMENT between the National Cancer Institute (NCI), a civilian agency within the Department of Health and Human Services (HHS), and Bio-Rad Laboratories, Inc. The contract has a ceiling value of $10,783.00 and a completion date of December 31, 2025. It was awarded on January 1, 2025 as a Firm Fixed Price Purchase Order. The contract does not have a set-aside designation. Bio-Rad Laboratories, Inc. is the prime contractor and is a global...
- This is a firm fixed-price purchase order contract awarded by the National Institute of Environmental Health Sciences (NIEHS), a civilian agency under the Department of Health and Human Services. The contract has a ceiling value of $15,159.00 and is for a maintenance agreement, with a period of performance ending on September 16, 2022. The prime contractor is Bio-Rad Laboratories, Inc., a global leader in developing and manufacturing products for life science research and clinical diagnostics....
- The National Cancer Institute (NCI), a civilian agency within the Department of Health and Human Services, awarded a $14,363.29 firm-fixed-price purchase order contract to Bio-Rad Laboratories, Inc. for a service contract to provide a Biorad Automated Droplet PCR System. The contract has an ultimate completion date of March 31, 2025. Bio-Rad Laboratories, Inc. is a global leader in life science research and clinical diagnostics products. The company has established relationships with multiple...
- This is a firm fixed-price purchase order contract awarded by the National Cancer Institute, a component of the National Institutes of Health (NIH), to Bio-Rad Laboratories, Inc. for the provision of various Bio-Rad real-time PCR systems. The contract has a total ceiling value of $11,685.88 and a completion date of December 31, 2024. Bio-Rad Laboratories is an experienced federal contractor, having previously provided specialized equipment, reagents, and services to various government agencies...
- This federal contract award, with ID 75N91020P00251, is for a maintenance agreement between the National Cancer Institute and Bio-Rad Laboratories, Inc. The $20,112.02 firm fixed-price contract does not have a set-aside designation. The contract was awarded on February 18, 2020 with an ultimate completion date of April 5, 2025. Bio-Rad Laboratories, Inc. is a global leader in developing and manufacturing products for life science research and clinical diagnostics. The company has established...
- Bio-Rad Laboratories, Inc. Life Science Group Division was awarded an $11,619.77 firm fixed price purchase order by the Department of Health and Human Services National Institutes of Health National Cancer Institute on April 1, 2019. The contract has a completion date of January 31, 2024 and no set-aside designation was used. This purchase order is associated with Bio-Rad Laboratories' five-year, $1 billion blanket purchase agreement with the Department of Health and Human Services National...
- This is a $346,770.62 firm fixed price purchase order awarded by the National Cancer Institute (NCI), which is part of the National Institutes of Health (NIH), to Bio-Rad Laboratories, Inc.'s Life Science Group Division. The contract is for the Laboratory of Receptor Biology and Gene Expression (LRGBE) to elucidate the mechanisms involved in the regulation of genetic expression in eukaryotic cells and identify the genes and regulatory processes involved in modulated states of expression. The...
- This is a one-year, firm-fixed-price purchase order awarded by the National Cancer Institute (NCI) to Bio-Rad Laboratories, Inc. Life Science Group Division for digital PCR maintenance services. The $23,808.00 contract has a completion date of September 28, 2025. No set-aside designation was used. This award is associated with Bio-Rad's $1 billion Blanket Purchase Agreement with the National Institutes of Health Office of Logistics and Acquisition Operations, which facilitates the procurement of...
This firm fixed-price purchase order contract was awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to Bio-Rad Laboratories, Inc. Life Science Group Division, a subsidiary of the parent company Bio-Rad Laboratories, Inc. The $18,625.40 contract is for a maintenance agreement, with a period of performance ending on April 5, 2025. Bio-Rad Laboratories, Inc. is an experienced federal contractor that has been awarded numerous contracts and sub-awards by various government agencies, primarily in the health and research sectors, to provide a range of biomedical research and testing products and services. This includes, but is not limited to, real-time PCR systems, thermal cyclers, gel imaging systems, digital droplet PCR instruments, multiplex assays, reagent kits, and associated maintenance and support services. Bio-Rad Laboratories, Inc. also holds several significant Indefinite Delivery Vehicles (IDVs) and Blanket Purchase Agreements (BPAs) with federal agencies, including a $1 billion BPA with the NIH Office of Logistics and Acquisition Operations for a wide range of materials and supplies. This particular contract award does not involve a set-aside designation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Funding Only Action | ($4k) | 3/31/25 | |
| Not listed | Not listed | $22.6k | 11/13/19 |